ONCOTELIC THERAPEUTICS
Oncotelic Therapeutics is a biopharmaceutical company seeking to realize the full potential of vascular targeted therapy (VTT) in orphan oncology indications. VTTs include vascular disrupting agents (VDAs) such as the investigational drugs that Oncotelic is developing, and anti-angiogenic agents (AAs), a number of which are FDA approved and widely used in cancer treatment. These 2 approaches (VDAs and AAs) have distinct yet complementary mechanisms of action. At Oncotelic, we believe that we can significantly improve cancer therapy by combining these 2 complementary approaches.
ONCOTELIC THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1988-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.oncotelic.com
Total Employee:
11+
Status:
Active
Contact:
(650) 635-7000
Email Addresses:
[email protected]
Total Funding:
7.5 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail IPv6 Google Maps GoDaddy DNS Google Maps API AWS Global Accelerator Akamai Hosted
Similar Organizations
Actimis Pharmaceuticals
Actimis Pharmaceuticals is a biopharmaceutical company developing small molecule therapeutics for respiratory and inflammatory disorders.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-11-04 | PointR Data | PointR Data acquired by Oncotelic Therapeutics | N/A |
| 2019-04-18 | Oncotelic | Oncotelic acquired by Oncotelic Therapeutics | N/A |
| 2009-10-01 | VaxGen | VaxGen acquired by Oncotelic Therapeutics | 33 M USD |
| 2009-07-03 | Symphony Vida | Symphony Vida acquired by Oncotelic Therapeutics | N/A |
Official Site Inspections
http://www.oncotelic.com
- Host name: biz267.inmotionhosting.com
- IP address: 23.235.222.9
- Location: El Segundo United States
- Latitude: 33.9214
- Longitude: -118.413
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90245
More informations about "Oncotelic Therapeutics"
About Us - Oncotelic
Oncotelic is an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. OT-101, the lead immuno-oncology drug candidate of …See details»
Oncotelic - Crunchbase Company Profile & Funding
Oncotelic is an immuno-oncology company developing RNA therapeutics and small molecule drugs against cancer and infectious diseases. It seeks to leverage its deep expertise in drug development to improve treatment outcomes and …See details»
Oncotelic - Crunchbase Company Profile & Funding
Oncotelic Inc. operates as a cancer immunotherapy company. The Company engaged in developing a unique TGF-b antisense therapy which has demonstrated the ability to break …See details»
Investor Overview - Oncotelic
Oncotelic is an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. OT-101, …See details»
Oncotelic Therapeutics, Inc. | Company Profile - OTC Markets
Oncotelic Therapeutics, Inc. (OTLC) are developing three lines of therapeutics. 1) Oncology/Virology - we are developing OT-101 (TGF-beta antisense/ Artemisinin).against …See details»
OncoTelic Company Profile 2024: Stock Performance & Earnings
OncoTelic General Information Description. Oncotelic Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing drugs for the treatment of orphan …See details»
Oncotelic Therapeutics Company Description - Stock Analysis
Nov 7, 2024 Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. It develops OXi4503 for …See details»
Oncotelic Therapeutics, Inc. Company Profile - Dun & Bradstreet
Doing Business As: Oncotelic. Company Description: Mateon Therapeutics (formerly OXiGENE) is a biopharmaceutical company focused on vascular targeted therapy in oncology, which …See details»
Oncotelic Overview | SignalHire Company Profile
Oncotelic is a private company that has been in the industry for 35 years. The company currently specializes in the Biotechnology, Pharmaceuticals, Biotechnology areas. ... Organization …See details»
Oncotelic, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Oncotelic, Inc. with its drug pipeline, therapeutic area, technology platform, 19 news, and 12 literature, Disease Domain:Endocrinology and Metabolic Disease ...See details»
Oncotelic - Overview, News & Similar companies | ZoomInfo.com
Mar 4, 2024 Oncotelic. Business Services · California, United States · <25 Employees. View Company Info for Free. About. Headquarters 29397 Agoura Rd Ste 107, Agoura Hills, …See details»
A TGF-beta Company - Oncotelic
Oct 26, 2021 Oncotelic C001-2020-01 IM Presentation 10. WWW.ONCOTELIC.COM Vascular Distruptor Agent (VDA) OXi4503: Mechanism-of-Action in AML • Phase 1B study was to define …See details»
Oncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy …
AGOURA HILLS, Calif., Aug. 25, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), announced today it was …See details»
Oncotelic Company Overview, Contact Details & Competitors
Expanded Portfolio Opportunities Oncotelic offers a lead asset, OT-101, designed for cancer and viral treatments like COVID-19, creating sales potential in multiple high-demand therapeutic …See details»
OTLC, Oncotelic, AI Powered Oncology | otcking.com
Feb 8, 2022 Oncotelic Therapeutics, OTLC, is a unique Immuno-Oncology company at the cutting edge of medical research and discovery of precision medicine ... Fein founded and has …See details»
Contact - Oncotelic
Oncotelic is an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. OT-101, …See details»
Oncotelic Therapeutics, Inc. (OTLC) - Yahoo Finance Canada
Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. It develops OXi4503 for the treatment …See details»
Press Releases - Oncotelic
Jul 29, 2024 Oncotelic is an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer and infectious …See details»
Pipeline - Oncotelic
Oncotelic is an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. OT-101, …See details»